GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CFO Buys Highlight: Information Services Group Inc., BioFuel Energy Corp., Oculus Innovative Sciences Inc., CalAmp Corp., Generex Biotechnology Corp.

November 22, 2009 | About:
gurujk

gurujk

5 followers
According to GuruFocus Insider Data, the largest CFO buys during the past week were Information Services Group Inc (III), BioFuel Energy Corp. (BIOF), Oculus Innovative Sciences Inc. (OCLS), BioFuel Energy Corp. (BIOF), and _Generex Biotechnology Corp. (GNBT).

Information Services Group Inc (III): Executive VP and CFO David E. Berger Bought 125,000 Shares

Executive VP and CFO of Information Services Group Inc (III) David E. Berger bought 125,000 shares on 11/12/2009 at an average price of $3.17. Information Services Group Inc has a market cap of $105.5 million; its shares were traded at around $3.35 with a P/E ratio of 11.6 and P/S ratio of 0.6.

Magnum Hunter Resources Inc. recently reported and financial results today for the third period 2009 ended September 30, 2009. Magnum Hunter reported a net loss of $3.1 million, or ($0.08) per basic and fully diluted shares outstanding for the third quarter of 2009, as compared to 2008's third quarter net loss of $535.5 thousand, or ($0.01) per basic and fully diluted shares outstanding.

Buy:: Chairman and CEO, 10% Owner Michael P Connors bought 315,457 shares of III stock on 11/12/2009 at the average price of 3.17, the price of the stock has increased by 5.68% since. Buy:: Executive VP and CFO David E. Berger bought 125,000 shares of III stock on 11/12/2009 at the average price of 3.17, the price of the stock has increased by 5.68% since. Sell:: 10% Owner Frank Martell sold 440,457 shares of III stock on 11/12/2009 at the average price of 3.17, the price of the stock has increased by 5.68% since. Sell:: 10% Owner Eric Semler sold 231,000 shares of III stock on 11/04/2009 at the average price of 3.47 and 94,900 shares of III stock on 11/05/2009 at the average price of 3.3, the price of the stock has increased by 1.52% since.

BioFuel Energy Corp. (BIOF): Vice President, CFO Kelly G. Maguire Bought 27,000 Shares

Vice President, CFO of BioFuel Energy Corp. (BIOF) Kelly G. Maguire bought 27,000 shares on 11/16/2009 at an average price of $1.47. Biofuel Energy Corp. has a market cap of $38.3 million; its shares were traded at around $1.52 with and P/S ratio of 0.2.

BioFuel Energy Corp. announced its third quarter results 2009. For the three months ended September 30, 2009, revenues totaled $91.1 million, which was comprised of $79.8 million from sales of ethanol and $11.3 million from sales of distillers grain. Net loss attributable to common shareholders was $6.2 million, or $.26 a share, for the three months ended September 30, 2009. The net loss for the three months ended September 30, 2009 was $8.4 million, which included $2.2 million of losses attributable to noncontrolling interests.

BIOF is in the portfolios of Daniel Loeb of Third Point, LLC, David Einhorn of Greenlight Capital Inc.

Buy:: President & CEO Scott H Pearce bought 10,000 shares of BIOF stock on 11/18/2009 at the average price of 1.48 and 5,416 shares of BIOF stock on 11/20/2009 at the average price of 1.41, the price of the stock has increased by 7.8% since.

Oculus Innovative Sciences Inc. (OCLS): CFO Robert E Miller Bought 13,000 Shares

CFO of Oculus Innovative Sciences Inc. (OCLS) Robert E Miller bought 13,000 shares on 11/11/2009 at an average price of $1.68. Oculus Innovative Sciences Inc. has a market cap of $33.2 million; its shares were traded at around $1.4 with and P/S ratio of 6.2.

Oculus Innovative Sciences, Inc. announced financial and operating results for the second quarter of fiscal year 2010, ended September 30. The net loss for the fiscal 2010 second quarter was $1.9 million, or $0.08 per share, compared with the net loss for the fiscal 2009 second quarter of $6.9 million, or $0.43 per share. The company reported total revenue of $1.7 million in the second quarter of fiscal 2010, compared to $1.5 million in the second quarter of fiscal 2009.

Sell:: CEO Hojabr Alimi sold 315,000 shares of OCLS stock on 08/10/2009 at the average price of 2.09, the price of the stock has decreased by 33.01% since. Buy:: Vice President James J Schutz bought 5,000 shares of OCLS stock on 08/12/2009 at the average price of 2.04, the price of the stock has decreased by 31.37% since. Sell:: Director Richard K Conley sold 25,000 shares of OCLS stock on 09/10/2009 at the average price of 2.77, the price of the stock has decreased by 49.46% since.

CalAmp Corp. (CAMP): VP Finance & CFO Richard K Vitelle Bought 10,000 Shares

VP Finance & CFO of CalAmp Corp. (CAMP) Richard K Vitelle bought 10,000 shares on 11/11/2009 at an average price of $3.01. Calamp Corp. has a market cap of $81.1 million; its shares were traded at around $3.15 with and P/S ratio of 0.8.

CalAmp Corp. reported results for its fiscal 2010 second quarter ended August 31, 2009. The company reported a net loss of $4.2 million, or $0.17 per diluted share and consolidated second quarter revenues of $23.9 million, within guidance and 4% higher than prior quarter.

Buy:: President & CEO Richard B Gold bought 17,106 shares of CAMP stock on 07/16/2009 at the average price of 1.16, 2,894 shares of CAMP stock on 07/17/2009 at the average price of 1.2, and 10,000 shares of CAMP stock on 10/14/2009 at the average price of 3, the price of the stock has increased by 5% since. Buy:: Director Frank Jr Perna bought 10,000 shares of CAMP stock on 08/11/2009 at the average price of 1.78, 7,900 shares of CAMP stock on 10/14/2009 at the average price of 3, 5,000 shares of CAMP stock on 10/21/2009 at the average price of 3.29, 7,100 shares of CAMP stock on 10/22/2009 at the average price of 3.23, and 10,000 shares of CAMP stock on 10/28/2009 at the average price of 3, the price of the stock has increased by 5% since.

Generex Biotechnology Corp. (GNBT): COO, CFO, Treas. & Secy. Rose C Perri Bought 10,000 Shares

COO, CFO, Treas. & Secy. of Generex Biotechnology Corp. (GNBT) Rose C Perri bought 10,000 shares on 11/16/2009 at an average price of $0.51. Generex Biotechnology Corp. has a market cap of $123.4 million; its shares were traded at around $0.5 with and P/S ratio of 111.3.

Buy:: CEO & Pres. Anna E Gluskin bought 10,000 shares of GNBT stock on 11/16/2019 at the average price of 0.51, the price of the stock has decreased by 1.96% since. Buy:: EVP & General Counsel Mark Fletcher bought 10,000 shares of GNBT stock on 11/13/2009 at the average price of 0.49, the price of the stock has increased by 2.04% since. Buy:: Director Nola E Masterson bought 50,000 shares of GNBT stock on 11/12/2009 at the average price of 0.5, 2,700 shares of GNBT stock on 10/19/2009 at the average price of 0.69, and 10,000 shares of GNBT stock on 11/13/2009 at the average price of 0.49, the price of the stock has increased by 2.04% since.

For the complete list of stocks that bought by their CFOs, go to: Insider Buys.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 3.5/5 (4 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK